Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemozoin formation (also called heme biocrystallization) is a critical process in the intraerythrocytic stages of Plasmodium parasites, where free heme, released during hemoglobin digestion, is detoxified by conversion into an insoluble crystalline pigment called hemozoin. This biocrystallization prevents the toxic effects of labile heme on the parasite. Historically, a unique "heme polymerase" enzyme was postulated to catalyze this process, but current evidence suggests that hemozoin formation is primarily a physicochemical event facilitated by the acidic vacuolar environment and possibly promoted by parasite proteins and lipids rather than a canonical enzyme[10]. This pathway represents a well-validated drug target for antimalarials such as chloroquine and related quinolines, which work by inhibiting hemozoin formation, leading to toxic buildup of free heme within the parasite, ultimately causing oxidative damage and parasite death[10].
Inhibition of hemozoin formation, leading to accumulation of toxic free heme and parasite death
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemozoin formation (heme biocrystallization).